-
1
-
-
9444272941
-
Perceptions of older people with cancer of information, decision making and treatment: A systematic review of selected literature
-
Chouliara Z, Kearney N, Stott D, Molassiotis A and Miller M: Perceptions of older people with cancer of information, decision making and treatment: A systematic review of selected literature. Ann Oncol 15: 1596-1602, 2004.
-
(2004)
Ann Oncol
, vol.15
, pp. 1596-1602
-
-
Chouliara, Z.1
Kearney, N.2
Stott, D.3
Molassiotis, A.4
Miller, M.5
-
2
-
-
84863979585
-
Predictors of early death risk in older patients treated with first-line chemotherapy for cancer
-
Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, Imbert Y, Cany L, Vogt L, Dauba J, et al: Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 30: 1829-1834, 2012.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1829-1834
-
-
Soubeyran, P.1
Fonck, M.2
Blanc-Bisson, C.3
Blanc, J.F.4
Ceccaldi, J.5
Mertens, C.6
Imbert, Y.7
Cany, L.8
Vogt, L.9
Dauba, J.10
-
3
-
-
84875448911
-
Relevance of a systematic geriatric screening and assessment in older patients with cancer: Results of a prospective multicentric study
-
Kenis C, Bron D, Libert Y, Decoster L, Van Puyvelde K, Scalliet P, Cornette P, Pepersack T, Luce S, Langenaeken C, et al: Relevance of a systematic geriatric screening and assessment in older patients with cancer: Results of a prospective multicentric study. Ann Oncol 24: 1306-1312, 2013.
-
(2013)
Ann Oncol
, vol.24
, pp. 1306-1312
-
-
Kenis, C.1
Bron, D.2
Libert, Y.3
Decoster, L.4
Van Puyvelde, K.5
Scalliet, P.6
Cornette, P.7
Pepersack, T.8
Luce, S.9
Langenaeken, C.10
-
4
-
-
79960185849
-
Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy
-
Aaldriks AA, Maartense E, le Cessie S, Giltay EJ, Verlaan HA, van der Geest LG, Kloosterman-Boele WM, Peters-Dijkshoorn MT, Blansjaar BA, van Schaick HW and Nortier JW: Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 79: 205-212, 2011.
-
(2011)
Crit Rev Oncol Hematol
, vol.79
, pp. 205-212
-
-
Aaldriks, A.A.1
Maartense, E.2
Le Cessie, S.3
Giltay, E.J.4
Verlaan, H.A.5
Van Der Geest, L.G.6
Kloosterman-Boele, W.M.7
Peters-Dijkshoorn, M.T.8
Blansjaar, B.A.9
Van Schaick, H.W.10
Nortier, J.W.11
-
5
-
-
84898894700
-
A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients
-
Zhong R, Han B and Zhong H: A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients. Tumour Biol 35: 987-994, 2014.
-
(2014)
Tumour Biol
, vol.35
, pp. 987-994
-
-
Zhong, R.1
Han, B.2
Zhong, H.3
-
6
-
-
84883013065
-
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features
-
Gammaitoni L, Giraudo L, Leuci V, Todorovic M, Mesiano G, Picciotto F, Pisacane A, Zaccagna A, Volpe MG, Gallo S, et al: Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features. Clin Cancer Res 19: 4347-4358, 2013.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 4347-4358
-
-
Gammaitoni, L.1
Giraudo, L.2
Leuci, V.3
Todorovic, M.4
Mesiano, G.5
Picciotto, F.6
Pisacane, A.7
Zaccagna, A.8
Volpe, M.G.9
Gallo, S.10
-
7
-
-
84875282081
-
Cytokine-induced killer cells promote antitumor immunity
-
Jiang J, Wu C and Lu B: Cytokine-induced killer cells promote antitumor immunity. J Transl Med 11: 83, 2013.
-
(2013)
J Transl Med
, vol.11
, pp. 83
-
-
Jiang, J.1
Wu, C.2
Lu, B.3
-
8
-
-
78751628167
-
Clinical trials on CIK cells: First report of the international registry on CIK cells (IRCC)
-
Hontscha C, Borck Y, Zhou H, Messmer D and Schmidt-Wolf IG: Clinical trials on CIK cells: First report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 137: 305-310, 2011.
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 305-310
-
-
Hontscha, C.1
Borck, Y.2
Zhou, H.3
Messmer, D.4
Schmidt-Wolf, I.G.5
-
9
-
-
84958950716
-
Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy
-
Turksma AW, Coupé VM, Shamier MC, Lam KL, de Weger VA, Belien JA, van den Eertwegh AJ, Meijer GA, Meijer CJ, Hooijberg E. Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy. Clin Cancer Res. 22: 346-356, 2016.
-
(2016)
Clin Cancer Res
, vol.22
, pp. 346-356
-
-
Turksma, A.W.1
Coupé, V.M.2
Shamier, M.C.3
Lam, K.L.4
De Weger, V.A.5
Belien, J.A.6
Van Den Eertwegh, A.J.7
Meijer, G.A.8
Meijer, C.J.9
Hooijberg, E.10
-
10
-
-
84906343606
-
A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma
-
Saito H, Ando S, Morishita N, Lee KM, Dator D, Dy D, Shigemura K, Adhim Z, Nibu K, Fujisawa M and Shirakawa T: A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma. Anticancer Res 34: 3365-3370, 2014.
-
(2014)
Anticancer Res
, vol.34
, pp. 3365-3370
-
-
Saito, H.1
Ando, S.2
Morishita, N.3
Lee, K.M.4
Dator, D.5
Dy, D.6
Shigemura, K.7
Adhim, Z.8
Nibu, K.9
Fujisawa, M.10
Shirakawa, T.11
-
11
-
-
84883244302
-
Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo
-
Huang J, Li C, Wang Y, Lv H, Guo Y, Dai H, Wicha MS, Chang AE and Li Q: Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo. Clin Immunol 149: 156-168, 2013.
-
(2013)
Clin Immunol
, vol.149
, pp. 156-168
-
-
Huang, J.1
Li, C.2
Wang, Y.3
Lv, H.4
Guo, Y.5
Dai, H.6
Wicha, M.S.7
Chang, A.E.8
Li, Q.9
-
12
-
-
84864347928
-
The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: A clinical retrospective study
-
Zhang J, Zhu L, Wei J, Liu L, Yin Y, Gu Y and Shu Y: The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: A clinical retrospective study. J Cancer Res Clin Oncol 138: 1057-1062, 2012.
-
(2012)
J Cancer Res Clin Oncol
, vol.138
, pp. 1057-1062
-
-
Zhang, J.1
Zhu, L.2
Wei, J.3
Liu, L.4
Yin, Y.5
Gu, Y.6
Shu, Y.7
-
13
-
-
84855606037
-
Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma
-
Lu XC, Yang B, Yu RL, Chi XH, Tuo S, Tuo CW, Zhu HL, Wang Y, Jiang CG, Fu XB, et al: Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma. Cell Biochem Biophys 62: 257-265, 2012.
-
(2012)
Cell Biochem Biophys
, vol.62
, pp. 257-265
-
-
Lu, X.C.1
Yang, B.2
Yu, R.L.3
Chi, X.H.4
Tuo, S.5
Tuo, C.W.6
Zhu, H.L.7
Wang, Y.8
Jiang, C.G.9
Fu, X.B.10
-
14
-
-
84899116386
-
Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients
-
Gao D, Li C, Xie X, Zhao P, Wei X, Sun W, Liu HC, Alexandrou AT, Jones J, Zhao R and Li JJ: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients. PLoS One 9: e93886, 2014.
-
(2014)
Plos One
, vol.9
-
-
Gao, D.1
Li, C.2
Xie, X.3
Zhao, P.4
Wei, X.5
Sun, W.6
Liu, H.C.7
Alexandrou, A.T.8
Jones, J.9
Zhao, R.10
Li, J.J.11
-
15
-
-
84924231322
-
Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer
-
Zhao P, Bu X, Wei X, Sun W, Xie X, Li C, Guo Q, Zhu D, Wei X and Gao D: Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer. Int Immunopharmacol 25: 450-456, 2015.
-
(2015)
Int Immunopharmacol
, vol.25
, pp. 450-456
-
-
Zhao, P.1
Bu, X.2
Wei, X.3
Sun, W.4
Xie, X.5
Li, C.6
Guo, Q.7
Zhu, D.8
Wei, X.9
Gao, D.10
-
16
-
-
84872488982
-
Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients
-
Yang L, Ren B, Li H, Yu J, Cao S, Hao X and Ren X: Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients. Cancer Immunol Immunother 62: 65-73, 2013.
-
(2013)
Cancer Immunol Immunother
, vol.62
, pp. 65-73
-
-
Yang, L.1
Ren, B.2
Li, H.3
Yu, J.4
Cao, S.5
Hao, X.6
Ren, X.7
-
17
-
-
84899757858
-
Inactivated human platelet lysate with psoralen: A new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions
-
Castiglia S, Mareschi K, Labanca L, Lucania G, Leone M, Sanavio F, Castello L, Rustichelli D, Signorino E, Gunetti M, et al: Inactivated human platelet lysate with psoralen: A new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. Cytotherapy 16: 750-763, 2014.
-
(2014)
Cytotherapy
, vol.16
, pp. 750-763
-
-
Castiglia, S.1
Mareschi, K.2
Labanca, L.3
Lucania, G.4
Leone, M.5
Sanavio, F.6
Castello, L.7
Rustichelli, D.8
Signorino, E.9
Gunetti, M.10
-
18
-
-
84891372505
-
Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5-a population-based study
-
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, et al: Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE-5-a population-based study. Lancet Oncol 15: 23-34, 2014.
-
(2014)
Lancet Oncol
, vol.15
, pp. 23-34
-
-
De Angelis, R.1
Sant, M.2
Coleman, M.P.3
Francisci, S.4
Baili, P.5
Pierannunzio, D.6
Trama, A.7
Visser, O.8
Brenner, H.9
Ardanaz, E.10
-
19
-
-
84890814629
-
Breakthrough of the year 2013. Cancer immunotherapy
-
Couzin-Frankel J: Breakthrough of the year 2013. Cancer immunotherapy. Science 342: 1432-1433, 2013.
-
(2013)
Science
, vol.342
, pp. 1432-1433
-
-
Couzin-Frankel, J.1
-
20
-
-
71149114221
-
Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery
-
Li H, Wang C, Yu J, Cao S, Wei F, Zhang W, Han Y and Ren XB: Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy 11: 1076-1083, 2009.
-
(2009)
Cytotherapy
, vol.11
, pp. 1076-1083
-
-
Li, H.1
Wang, C.2
Yu, J.3
Cao, S.4
Wei, F.5
Zhang, W.6
Han, Y.7
Ren, X.B.8
-
21
-
-
84890854644
-
Can the dual-functional capability of CIK cells be used to improve antitumor effects?
-
Wang X, Yu W, Li H, Yu J, Zhang X, Ren X and Cao S: Can the dual-functional capability of CIK cells be used to improve antitumor effects? Cell Immunol 287: 18-22, 2014.
-
(2014)
Cell Immunol
, vol.287
, pp. 18-22
-
-
Wang, X.1
Yu, W.2
Li, H.3
Yu, J.4
Zhang, X.5
Ren, X.6
Cao, S.7
-
22
-
-
84947504060
-
DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T cell tolerance and inhibit diabetes
-
Price JD, Hotta-Iwamura C, Zhao Y, Beauchamp NM and Tarbell KV: DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T cell tolerance and inhibit diabetes. Diabetes 64: 3521-3531, 2015.
-
(2015)
Diabetes
, vol.64
, pp. 3521-3531
-
-
Price, J.D.1
Hotta-Iwamura, C.2
Zhao, Y.3
Beauchamp, N.M.4
Tarbell, K.V.5
-
23
-
-
84931449915
-
Cytokine-induced killer (CIK) cells in cancer immunotherapy: Report of the international registry on CIK cells (IRCC)
-
Schmeel LC, Schmeel FC, Coch C and Schmidt-Wolf IG: Cytokine-induced killer (CIK) cells in cancer immunotherapy: Report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 141: 839-849, 2015.
-
(2015)
J Cancer Res Clin Oncol
, vol.141
, pp. 839-849
-
-
Schmeel, L.C.1
Schmeel, F.C.2
Coch, C.3
Schmidt-Wolf, I.G.4
-
24
-
-
84940990114
-
Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer
-
Mao Q, Li L, Zhang C, Sun Y, Liu S and Cui S: Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer. Pak J Pharm Sci 28 (Suppl 3): S1055-S1058, 2015.
-
(2015)
Pak J Pharm Sci
, vol.28
, pp. S1055-S1058
-
-
Mao, Q.1
Li, L.2
Zhang, C.3
Sun, Y.4
Liu, S.5
Cui, S.6
-
25
-
-
84930635662
-
Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer
-
Wang S and Wang Z: Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer. Int Immunopharmacol 28: 22-28, 2015.
-
(2015)
Int Immunopharmacol
, vol.28
, pp. 22-28
-
-
Wang, S.1
Wang, Z.2
|